Farbridge Pharma Consulting

Farbridge Pharma Consulting is a US-based, private consulting firm founded in 2018, specializing in GxP Quality Assurance for the life sciences industry. The company's core service is acting as a strategic bridge for clients seeking to establish compliant operations in new countries, offering expertise in quality system implementation, global auditing, and regulatory gap assessments. With a founder-led team of international experts, it targets biotech and pharma companies needing to navigate complex, multi-regional compliance landscapes. Its business model is entirely service-based, generating revenue through consulting engagements and training programs.

The company does not have a proprietary technology platform. Its core asset is a global network of expert GxP consultants and standardized methodologies for quality system gap analysis, implementation, and auditing.

Farbridge competes in the crowded life sciences quality and regulatory consulting market. Competitors range from large global CROs (e.g., IQVIA, Parexel) with consulting divisions to numerous boutique specialty firms. Its key differentiator is its focused expertise in bridging specific geographic regulatory requirements (e.g., US-EU) and its foundation in European QP knowledge.